VeriMomrh-polypeptide-17 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment was found for rh‑polypeptide‑17 (CAS 722588‑92‑3). No peer‑reviewed reproductive or developmental toxicity data were identified in available sources (PubMed, PubChem, CosIng), and peptides of this size are generally considered to have negligible dermal absorption from cosmetic use, so default hazard/mechanism/exposure scores are 0. Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem, CosIng.
Related ingredients
Frequently asked questions
- rh-polypeptide-17 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment was found for rh‑polypeptide‑17 (CAS 722588‑92‑3). No peer‑reviewed reproductive or developmental toxicity data were identified in available sources (PubMed, PubChem, CosIng), and peptides of this size are generally considered to have negligible dermal absorption from cosmetic use, so default hazard/mechanism/exposure scores are 0. Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem, CosIng.
- rh-polypeptide-17 est-il sûr pendant l'allaitement ?
- No data indicating reproductive or lactation toxicity or systemic transfer in humans/animals was identified. Given lack of hazard data and expected minimal dermal absorption for a peptide, breastfeeding risk is scored as 0/0/0 based on available regulatory and literature sources (no entries in CIR/SCCS/ECHA harmonised lists).
- rh-polypeptide-17 est-il sûr pour la peau de bébé ?
- No infant‑specific data found. Because adult dermal absorption is expected to be negligible but not provably zero for a peptide, exposure for baby skin (0–3 yr) is increased by +1 to reflect higher surface‑area‑to‑weight and immature barrier; no evidence of specific developmental hazard or mechanism was identified. Sources: PubMed (no studies), CosIng/PubChem (ingredient listings), ECHA (no harmonised classification).
- Comment VeriMom évalue-t-il rh-polypeptide-17 ?
- VeriMom évalue rh-polypeptide-17 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à rh-polypeptide-17 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à rh-polypeptide-17 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.